{"id":"https://openalex.org/W184480178","doi":"https://doi.org/10.1177/106002809502900210","title":"Sulpiride: an Antipsychotic with Selective Dopaminergic Antagonist Properties","display_name":"Sulpiride: an Antipsychotic with Selective Dopaminergic Antagonist Properties","publication_year":1995,"publication_date":"1995-02-01","ids":{"openalex":"https://openalex.org/W184480178","doi":"https://doi.org/10.1177/106002809502900210","mag":"184480178","pmid":"https://pubmed.ncbi.nlm.nih.gov/7756714"},"language":"en","primary_location":{"id":"doi:10.1177/106002809502900210","doi":"https://doi.org/10.1177/106002809502900210","is_oa":false,"landing_page_url":"https://doi.org/10.1177/106002809502900210","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086462893","display_name":"Charles F. Caley","orcid":"https://orcid.org/0000-0002-6047-1053","observed_orcids":["https://orcid.org/0000-0002-6047-1053"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charles F. Caley","raw_affiliation_strings":["Diagnostek, Taunton State Hospital, Taunton, MA 02780"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diagnostek, Taunton State Hospital, Taunton, MA 02780","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103652952","display_name":"Stanley S. Weber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170632171","display_name":"Washington State University Spokane","ror":"https://ror.org/04vfs5h36","country_code":"US","type":"education","lineage":["https://openalex.org/I170632171","https://openalex.org/I72951846"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stanley S. Weber","raw_affiliation_strings":["College of Pharmacy, Washington State University, Spokane, WA 99204, and Psychiatric Pharmacotherapeutic Specialist, Eastern State Hospital, Medical Lake, WA 99022"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Pharmacy, Washington State University, Spokane, WA 99204, and Psychiatric Pharmacotherapeutic Specialist, Eastern State Hospital, Medical Lake, WA 99022","institution_ids":["https://openalex.org/I170632171"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":1.7059,"has_fulltext":false,"cited_by_count":261,"citation_normalized_percentile":{"value":0.81734544,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"29","issue":"2","first_page":"152","last_page":"160"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sulpiride","display_name":"sulpiride","score":1.0},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8090000152587891},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9869999885559082},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-antagonism","display_name":"dopamine D2 receptor antagonism","score":0.7689999938011169},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.972000002861023},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.7670000195503235},{"id":"https://openalex.org/keywords/renal-excretion","display_name":"renal excretion","score":0.7979999780654907},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.8149999976158142},{"id":"https://openalex.org/keywords/tardive-dyskinesia","display_name":"tardive dyskinesia","score":0.9959999918937683},{"id":"https://openalex.org/keywords/neuroleptic-malignant-syndrome","display_name":"neuroleptic malignant syndrome","score":0.9990000128746033},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6779999732971191},{"id":"https://openalex.org/keywords/negative-symptoms","display_name":"negative symptoms","score":0.8610000014305115}],"concepts":[{"id":"https://openalex.org/C2780806966","wikidata":"https://www.wikidata.org/wiki/Q422418","display_name":"Sulpiride","level":4,"score":0.9531246423721313},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6769348978996277},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.5998356342315674},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5669429302215576},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.5657858848571777},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.5285112857818604},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5248984098434448},{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.5165073275566101},{"id":"https://openalex.org/C2781353949","wikidata":"https://www.wikidata.org/wiki/Q3271533","display_name":"Dopamine antagonist","level":4,"score":0.41956645250320435},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.41856181621551514},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37688782811164856},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.27819955348968506},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2505456805229187},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.19340986013412476},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.17436549067497253}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001342","descriptor_name":"Autonomic Nervous System Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D001480","descriptor_name":"Basal Ganglia Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011954","descriptor_name":"Receptors, Dopamine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013469","descriptor_name":"Sulpiride","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013469","descriptor_name":"Sulpiride","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013469","descriptor_name":"Sulpiride","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013469","descriptor_name":"Sulpiride","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/106002809502900210","doi":"https://doi.org/10.1177/106002809502900210","is_oa":false,"landing_page_url":"https://doi.org/10.1177/106002809502900210","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:7756714","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7756714","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Annals of pharmacotherapy","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W88468646","https://openalex.org/W1568992048","https://openalex.org/W1861701908","https://openalex.org/W1963796547","https://openalex.org/W1966092598","https://openalex.org/W1973934475","https://openalex.org/W1990445980","https://openalex.org/W1991724312","https://openalex.org/W1998302082","https://openalex.org/W2010236462","https://openalex.org/W2014151243","https://openalex.org/W2014367145","https://openalex.org/W2014978199","https://openalex.org/W2017549779","https://openalex.org/W2021092126","https://openalex.org/W2021482497","https://openalex.org/W2025203404","https://openalex.org/W2026812180","https://openalex.org/W2029237088","https://openalex.org/W2032931273","https://openalex.org/W2041863334","https://openalex.org/W2043580436","https://openalex.org/W2044236179","https://openalex.org/W2048081131","https://openalex.org/W2049017069","https://openalex.org/W2058195692","https://openalex.org/W2061359205","https://openalex.org/W2064250035","https://openalex.org/W2065012733","https://openalex.org/W2065240317","https://openalex.org/W2065256090","https://openalex.org/W2066753343","https://openalex.org/W2072069319","https://openalex.org/W2077613808","https://openalex.org/W2080023028","https://openalex.org/W2080709711","https://openalex.org/W2080889861","https://openalex.org/W2081209440","https://openalex.org/W2089261085","https://openalex.org/W2113637843","https://openalex.org/W2119782417","https://openalex.org/W2120194850","https://openalex.org/W2279841686","https://openalex.org/W2334067492","https://openalex.org/W2406022298","https://openalex.org/W2415609077","https://openalex.org/W2417452143","https://openalex.org/W2419378042","https://openalex.org/W2426567195","https://openalex.org/W2508396631","https://openalex.org/W2887788245","https://openalex.org/W4210956182"],"related_works":["https://openalex.org/W1973187970","https://openalex.org/W1978653812","https://openalex.org/W2409783939","https://openalex.org/W2035308479","https://openalex.org/W7216816406","https://openalex.org/W1495131943","https://openalex.org/W189014912","https://openalex.org/W2415578091","https://openalex.org/W2014151243","https://openalex.org/W2756349991"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"review":[2],"the":[3,34,213,227,253,268,283,307,326],"pharmacology,":[4],"pharmacokinetics,":[5],"clinical":[6,76,239],"investigations,":[7],"and":[8,57,83,107,118,153,206,263,282,302],"adverse":[9,92,291],"effects":[10],"of":[11,27,39,60,69,91,176,230,255,261,271,289,310],"sulpiride":[12,140,149,177,218,256,320],"as":[13,33,219,223,257],"a":[14,24,52,70,79,127,258,300,322],"treatment":[15,58,81,229,260,305],"for":[16,89,101,143,306],"schizophrenia.":[17,233,272,311],"DATA":[18,95,123],"SOURCES:":[19],"Information":[20],"was":[21,73,141],"selected":[22,114],"from":[23,110,242],"MEDLINE":[25],"search":[26,35],"English-language":[28],"medical":[29],"literature":[30],"using":[31,78],"\"sulpiride\"":[32],"term.":[36],"Manual":[37],"searches":[38],"pertinent":[40],"journal":[41],"article":[42],"bibliographies":[43],"also":[44,150],"were":[45,65,87,99,113],"performed.":[46],"STUDY":[47],"SELECTION:":[48],"Clinical":[49,97,215],"investigations":[50,98,112,240],"with":[51,130,180,232,321,333],"blind,":[53],"controlled,":[54],"randomized":[55],"design":[56],"durations":[59],"at":[61],"least":[62],"6":[63],"weeks":[64],"preferred.":[66],"Formal":[67],"assessment":[68],"patient's":[71],"schizophrenia":[72,262],"required.":[74],"One":[75],"investigation":[77,86,248],"4-week":[80],"duration":[82],"1":[84,116],"open":[85],"included":[88],"purposes":[90],"reaction":[93],"assessment.":[94],"EXTRACTION:":[96],"evaluated":[100],"design,":[102],"sample":[103],"size,":[104],"diagnosis,":[105],"duration,":[106],"outcome.":[108],"Data":[109],"all":[111],"by":[115,120],"author":[117],"reviewed":[119],"both":[121],"authors.":[122],"SYNTHESIS:":[124],"Sulpiride":[125,156,184,273,298],"is":[126,178,195,249,299],"substituted":[128],"benzamide":[129],"selective":[131,142],"dopaminergic":[132],"blocking":[133],"activity.":[134],"Early":[135],"pharmacology":[136,314],"reports":[137],"hypothesized":[138],"that":[139],"dopamine":[144],"(D)2":[145],"receptors":[146,168],"only,":[147],"but":[148,329],"blocks":[151],"D3":[152],"D4":[154],"receptors.":[155],"does":[157,185,315],"not":[158,186,294,316],"block":[159],"D1,":[160],"adrenergic,":[161],"cholinergic,":[162],"gamma-aminobutyric":[163],"acid-ergic,":[164],"histaminergic,":[165],"or":[166],"serotonergic":[167],"to":[169,188,209,244,251,318],"an":[170,190],"appreciable":[171],"extent.":[172],"The":[173,287],"oral":[174],"bioavailability":[175],"poor,":[179],"estimates":[181],"approximating":[182],"35%.":[183],"appear":[187,317],"have":[189,200],"extensive":[191],"first-pass":[192],"metabolism,":[193],"nor":[194],"it":[196,332],"extensively":[197],"protein-bound.":[198],"There":[199],"been":[201,295],"no":[202],"identified":[203],"active":[204,224],"metabolites,":[205],"elimination":[207],"appears":[208],"depend":[210],"primarily":[211],"on":[212],"kidneys.":[214],"studies":[216],"support":[217],"being":[220],"equally":[221],"effective":[222,303],"controls":[225],"in":[226,237,266],"acute":[228,308],"patients":[231],"Daily":[234],"doses":[235],"permitted":[236],"these":[238,290],"ranged":[241],"100":[243],"3200":[245],"mg.":[246],"Further":[247],"required":[250],"determine":[252],"usefulness":[254],"chronic":[259],"its":[264],"effectiveness":[265,324],"treating":[267],"negative":[269],"symptoms":[270],"may":[274,330],"cause":[275],"extrapyramidal":[276],"effects,":[277,279],"autonomic":[278],"tardive":[280],"dyskinesia,":[281],"neuroleptic":[284],"malignant":[285],"syndrome.":[286],"incidence":[288],"reactions":[292],"has":[293],"established.":[296],"CONCLUSIONS:":[297],"safe":[301],"pharmacotherapeutic":[304],"management":[309],"A":[312],"unique":[313],"provide":[319,331],"greater":[323],"than":[325],"standard":[327],"antipsychotics,":[328],"minor":[334],"safety":[335],"advantages.":[336]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":162},{"year":2019,"cited_by_count":3},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}